Targets & Tools: High Content Analysis
Showcasing novel applications for use in the drug discovery process
Join us for a case-study packed programme presenting the latest developments in HCA assay design and the impact of HCA on drug discovery research from key academic institutions and leading industry organisations, including AstraZeneca, Sanofi-Aventis, Schering-Plough, Merck and many more....
Do not miss the opportunity to explore the potential of HCA for in vitro toxicology studies, primary, stem, live and tissue cell screening, 3D imaging, bio therapeutic research and label-free technologies.
This ‘must-attend’ conference has been thoroughly researched and specifically tailored for all those working on HCA from pharmaceutical, biotech and academic research institutions.
Highlights of High Content Analysis 2010
Industry and academic insights into HCA's most challenging issues:
- HCA for Primary, Stem and Tissue Cells read more
- Successfully utilising HCA for compound screening and toxicology studies read more
- 3D (Co-) Cultures and HCA read more
- Label free screening read more
- HCA in Biotherapeutic Research read more
- Creating a forum which encourages discussion and the exchange of knowledge read more
2010 Speaker Panel: The Best of Industry and Academia
2010 Speaker Panel: The Best of Industry and Academia
Marc Bickle
HT- Technology Development Studio,
Max Planck Institute CBG,
|
Eberhard Krausz
Director, Assay Development & Target Validation
Johnson & Johnson
|
Willem Schoonen
Senior Research Scientist
MSD
|
Hakim Djaballah
Director HTS Core Facility
Memorial Sloan Kettering Cancer Center
|
Peter O’Brien,
Veterinary Clinical Pathologist
University College Dublin
|
John Gatfield
Senior Lab Head Molecular Cell Biology
Actelion Pharmaceuticals Ltd
|
Meina Liang
Associate Director, Global PKPD&Bioanalysis
MedImmune
|
Jan Martin Berke
Scientist HCV Virology
Tibotec BVBA
|
Sponsors
Exhibitors
Explore these co-located events...
Dates and Venues
17 Mar 2010 - 18 Mar 2010
Maritim proArte Hotel
Organisations that attended in 2009 include:
16 March 2010: Pre-Conference Workshop
HCA- Getting the Most out of your Data
This interactive workshop will guide you through the aspects of data analysis, integration, reduction and management through a combination of presentations, small group exercises and discussions, in order to increase understanding of how to capitalise on this technology.
Led by:
Karol Kozak, HCS Informatics, LMC-RISC, ETH Zurich, Switzerland
Nikolaus Machuy, Head of Screening Unit, Max Planck Institute for Infection Biology, Berlin
Anthony Davies, HCA Research Facility Manager, Trinity College Dublin, Ireland
16th March Pre-Conference Symposium
Exploring Protein – Protein Interactions as Drug Targets
One of the most interesting aspects in this field at the moment is not the drug targets themselves, but the interaction with other proteins. This workshop will led you through this complex and emerging field.
This symposium will be led by:
Eberhard Krausz, Director, Discovery Assay Technologies (DAT), Tibotec BVBA, Belgium
Ola Söderberg, Associate Professor, Uppsala University, Sweden
Ulrich Stelzl, Max Planck Institute for Molecular Genetics (MPI-MG), Germany
Enno Klussmann, Group Leader, Leibniz-Institut für Molekulare Pharmakologie (FMP), Germany
Thomas P. Burris, Department of Molecular Therapeutics, The Scripps Research Institute, United States
Vincent Cavaillès, Ph.D., Group leader, INSERM U896 – IRCM, Montpellier, France
Join Informa Life Sciences' Targets and Tools LinkedIn Group and stay connected with industry peers throughout the year
Sponsors
Spotlight Session Hosts
Feedback from Targets and Tools 2009
"Excellent meeting overall for keeping up with advances in the field"
"Overall a great mix of academic and industry, as well as a good mix of industry and science"
